Old Gilly's screen shot of sections (d) Contract and Cost Risk
(e) Technology Risk
(f) Intellectual Property
are essential reading for any potential investor in TV2U. Hopefully everyone investing here read these statements as they are to me IMO at the core of what commercially can happen in the industry TV2U is engaging in.
IMO with respect to the Intellectual Property section one needs to carefully read the first two sentences carefully and consider how they may be interpreted or un-picked into potential actual true meaning or relevant meaning as they are by nature generalisations IMO.
"TV2U AND TV2U SINGAPORE HAVE LICENCED - this can be interpreted as having either an exclusive or a non-exclusive licence from the entity which licenced it to them IMO(whether TARA IP LTD or TALICO?)
OR ACQUIRED THE RIGHTS TO CERTAIN PATENT APPLICATIONS RELATING TO THEIR CORE BUSINESS. - this can be interpreted as meaning either exclusive or non-exclusive rights to those patents IMO.
The next sentence IMO makes it clear that another entity owns the actual patents(whether TARA IP LTD or TALICO?) as the sentence reads NONE OF THE PATENT APPLICATIONS ARE HELD IN THE NAME OF TV2U OR TV2U SINGAPORE .... and the sentence concludes with stating that at the time of that cleansing prospectus that none of the relevant pending patents had been granted.
IMO My interpretation of this wording is it is either just vague sloppy wording or it could also give the appearance of being consciously crafted that way to be able to be interpreted either way. In essence IMO it cannot be relied upon to assume TV2U and it shareholders own anything other than potentially a non-exclusive licence or rights from the third party to TV2U technologies.
This is important to the way I personally invest as what this could potentially entertain IMO in a worst case scenario is if TV2U slips into Voluntary Administration then the entities and their beneficial parties can sail off into the sunset with their original retained IP and use it for other possibilities and applications without much downside or recourse to us shareholders based on interpreting.
What is not clear to me personally is what our very large R&D expenditure over the last 18 months has been applied against, and who benefits from that in the event of voluntary liquidation? What firewalls exist to prevent any conflict of interest emerging here if things fail as TV2U is constructed around a number of TV2U entities and how that all works is not clear to me at least?
How would shareholder funds be accounted for in the event of developed artefacts from shareholder derived funds be identified and warehoused for liquidation purposes? I raise this only as IMO the risk profile of TV2U increases as the days go one without funding being announced as secured for preserving ASX provisions to continue trading exist beyond July quarter Q3 2017.
Given TV2U announcements have had a history of not realising substance, I have reduced my large shareholding in recent times to reflect my concerns. I still hold millions of shares and oppies and like everyone I am awaiting a positive announcement but shareholder discussion about what happens next in the event of a worst case outcome is a logical and useful discussion where we are right now IMO.
- Forums
- ASX - By Stock
- Alan Boyd..The Big Picture..
Old Gilly's screen shot of sections (d) Contract and Cost Risk...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TV2 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online